ArticleFrontiers in oncology2024

Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination.

Elisa Zanini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.